Protocol Title:- A Phase III, Multi-National, Multi-Center, Randomized, Masked, Controlled, Safety and Efficacy Study of a Fluocinolone Acetonide Intravitreal (FAI) Insert in Subjects with Chronic Non-Infectious Uveitis Affecting the Posterior Segment of the Eye.
Protocol No:- PSV-FAI-005
Protocol Title:- A Multi-Center, Controlled, Safety and Efficacy Study of a Fluocinolone Acetonide Intravitreal (FAI) Insert in Subjects with Chronic Non-Infectious Uveitis affecting the Posterior Segment of the Eye.
Protocol Title:- A Phase 2/3, Randomized, Double-Masked, Sham-Controlled Trial of QPI- 1007 Delivered by Single or Multi-Dose Intravitreal Injection(s) to Subjects with Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION).
Protocol Title:- PEACHTREE: A Phase 3, RandomizEd, MAsked, Controlled Clinical Trial to Study the Safety and Efficacy of Triamcinolone Acetonide Injectable Suspension CLS-TA)for the Treatment of Subjects with Macular Edema associated with Non - Infectious UvEitis
Protocol Title:-A prospective, multicenter clinical study to assess safety immunogenicity and efficacy of Ranibizumab (Intas Pharmaceutical Limited) for the treatment of wet AMD (Age Related Macular Degeneration).
Protocol Title:- “Evaluation and efficacy and safety of two fixed dose combination of carbonic anhydrate inhibitor and beta blocker for the treatment of elevated intraocular pressure in patients with ocular hypertension or open angle glaucoma a randomized open label, comparative, multicentric study.”
Protocol No:- WAT/BNZL/2014
Protocol Title:- A multicentre, double blind, active controlled, parallel group, two arm, bioequivalence study with clinical endpoint comparing Brinzolamide 1% ophthalmic suspension (manufactured by Indoco Remedies Ltd., for Watson PharmaPvt Ltd.), to Brinzolamide (Azopt®) 1% ophthalmic suspension of Alcon Laboratories Inc., in the treatment of Chronic open angle glaucoma or Ocular hypertension in both eye.
Protocol No:- WAT/LTPNL/2015
Protocol Title:- An Open Label, Randomized, Multicentric, Two Treatment, Single Dose, Parallel Group Two Stage Adaptive Design Bioequivalence Study of Loteprednol Etabonate Ophthalmic Suspension, 0.5 % in Aqueous Humor of Patients Undergoing Indicated Cataract Surgery”
Protocol No:- EXJ821-P001 (C-13-039)
Protocol Title:- Clinical Evaluation of Systane® Balance on Corneal Staining in Indian Subjects with Dry Eye.
PBMA's H. V. Desai Eye Hospital, 93, Tarwade Vasti, Mohammadwadi road, Hadapsar, Pune MH 411060 India
+91-20-26970144 | 26970043
+91-20-30114000 | 30114201
Mon to Fri - 8:00 am to 4:00 pm
Mon to Fri - 5:00 pm to 7:00 pm
Saturday : 8:00 am to 2:00 pm
Sunday : Closed
We are happy to answer your questions at email@example.com